Risperidone
Back to searchMolecule Structure
Scientific Name
Risperidone
Description of the Drug
Risperidone is a second-generation antipsychotic medication used to treat a number of mental health disorders including schizophrenia, bipolar mania, psychosis, or as an adjunct in severe depression.
Source: DrugBank Online – DrugBank.com. Retrieved 2023-03-10 from
http://www.drugbank.ca/drugs/DB00734
http://www.drugbank.ca/drugs/DB00734
Brand Name(s)
Perseris kit, Risperdal, Risperdal consta, Risperdal Consta Long Acting, Risperdal M, Risperdal M-Tab, Risperdal quicklet, Risperidone
Company Owner(s)
Jubilant Generics Ltd, Sun Pharmaceutical Industries Inc, Watson Laboratories Inc, Taro Pharmaceuticals Usa Inc, Mylan Pharmaceuticals Inc, Atlantide Pharmaceuticals Ag, Amneal Pharmaceuticals Llc, Zydus Pharmaceuticals Usa Inc, Prinston Pharmaceutical Inc, Torrent Pharmaceuticals Ltd
Mechanism(s) Of Action
| Target Name | Target Type | Action Type | Target ChEMBL ID |
|---|---|---|---|
| Dopamine D2 receptor | SINGLE PROTEIN | ANTAGONIST | CHEMBL217 |
| Serotonin 2c (5-HT2c) receptor | SINGLE PROTEIN | ANTAGONIST | CHEMBL225 |
| Serotonin 2a (5-HT2a) receptor | SINGLE PROTEIN | ANTAGONIST | CHEMBL224 |
Clinical Trial(s)
Unichem Links
| SureChEMBL | SCHEMBL27911 | ||
| PharmGKB | PA451257 | ||
| Human Metabolome Database | HMDB0005020 | ||
| DrugBank | DB00734 | ||
| PubChem: Thomson Pharma | 14904216 | ||
| PubChem | 5073 | ||
| Mcule | MCULE-4027175053 | ||
| LINCS | LSM-3193 | ||
| Nikkaji | J138.382E | ||
| PDBe | 8NU | ||
| BindingDB | 50001885 | ||
| EPA CompTox Dashboard | DTXSID8045193 | ||
| DrugCentral | 2389 | ||
| Brenda | 145986 | 145072 | 26594 |
| ChemicalBook | CB9131730 | CB63154711 | CB41565182 |
| Guide to Pharmacology | 96 | ||
| rxnorm | RISPERIDONE | RISPERDAL | PERSERIS |
| PubChem: Drugs of the Future | 12013967 | ||
| ChEBI | 8871 | ||
| ZINC | ZINC000000538312 |
